secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evelo Biosciences, Inc. (—)
CIK:        0001694665
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001694665-23-000027
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Evelo Biosciences receives Nasdaq notice for bid price below $1; 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq letter on March 16, 2023: stock closed below $1.00 for 30 consecutive business days.
- Initial compliance period ends Sept 12, 2023; must close at $1.00+ for 10 consecutive days.
- If not cured, may transfer to Nasdaq Capital Market for an additional 180-day period.
- Company may consider a reverse stock split, subject to board and stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000027/0001694665-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1694665/000169466523000027/evlo-20230316.htm
  HTML page:      https://secwatch.observer/filing/0001694665-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer